Lymphoblastic Lymphoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

FDA label_change · 2023-11-29
FDA Approved: ASPARLAS — Supplemental Application (Servier Pharmaceuticals LLC)
FDA approved a supplemental application for ASPARLAS (calaspargase pegol) from Servier Pharmaceuticals LLC, resulting in changes to the prod…